Pre-capillary PH (n=39) | Post-capillary PH (n=59) | P | |
Age (year) | 52.90±24.13 | 57.12±17.63 | 0.351 |
Male, n (%) | 17(43.58%) | 33(55.93 %) | 0.302 |
BSA (kg/m2) | 1.46±0.43 | 1.54±0.35 | 0.369 |
BMI(kg/m²) | 21.60±4.00 | 22.73±3.96 | 0.183 |
HR (1/min) | 84.07±11.38 | 79.24±16.98 | 0.195 |
Systolic Blood Pressure (mmHg) | 120.92±23.27 | 128.04±23.30 | 0.151 |
Diastolic Blood Pressure (mmHg) | 72.11±11.71 | 73.52±14.36 | 0.618 |
Atrial fibrillation, n (%) | 5(12.82%) | 14(23.72%) | 0.204 |
Classification (NICE) n (%) | |||
Group 1 | 13(33.33 %) | 1(1.69%) | |
Group 2 | 3(7.69%) | 53(89.83%) | |
Group 3 | 8(20.51%) | 0 | |
Group 4 | 7(17.95%) | 0 | |
Group 5 | 8(20.51%) | 5(8.77%) | |
NT Pro-BNP (pg/mL) | 629 (245.5, 1333) | 4355 (1804.25, 18559) | <0.001 |
hemoglobin (g/L) | 121.75±26.63 | 107.47±26.27 | 0.014 |
creatinine(umol/L) | 99 (67.75, 208.25) | 112 (72, 441) | 0.414 |
HbA1C (%) | 5.56±0.35 | 6.07±0.86 | 0.016 |
PAWP (mmHg) | 11.68±2.72 | 19.38±4.16 | <0.001 |
BSA:body surface area ;BMI:body mass index; HbA1C: glycosylated hemoglobin; PAWP: pulmonary arterial wedge pressure. | BSA:body surface area ;BMI:body mass index; HbA1C: glycosylated hemoglobin; PAWP: pulmonary arterial wedge pressure. | BSA:body surface area ;BMI:body mass index; HbA1C: glycosylated hemoglobin; PAWP: pulmonary arterial wedge pressure. | BSA:body surface area ;BMI:body mass index; HbA1C: glycosylated hemoglobin; PAWP: pulmonary arterial wedge pressure. |